Utility of oncotype DX risk estimates in clinically intermediate risk hormone receptor-positive, HER2-normal, grade II, lymph node-negative breast cancers.

Academic Article

Publication Date:

2010

Short description:

Utility of oncotype DX risk estimates in clinically intermediate risk hormone receptor-positive, HER2-normal, grade II, lymph node-negative breast cancers / Kelly, C.m., Krishnamurthy, S., Bianchini, G., Litton, J.k., Gonzalez-Angulo, A.m., Hortobagyi, G.n., Pusztai, L.. - In: CANCER. - ISSN 0008-543X. - (2010).

Iris type:

1.1 Articolo in rivista

List of contributors:

Kelly, Cm; Krishnamurthy, S; Bianchini, G; Litton, Jk; Gonzalez-Angulo, Am; Hortobagyi, Gn; Pusztai, L

Authors of the University:

BIANCHINI GIAMPAOLO

Handle:

https://iris.unisr.it/handle/20.500.11768/153889

Published in:

CANCER

Journal